Chemomab Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CMMB and other ETFs, options, and stocks.About CMMB
Chemomab Therapeutics Ltd. is a clinical-stage biotech company, which engages in the provision of therapeutics for conditions with unmet need that involve Inflammation and fibrosis. The company was founded by Adi Mor on September 22, 2011 and is headquartered in Tel Aviv, Israel.
CEOAdi Mor
CEOAdi Mor
Employees12
Employees12
HeadquartersTel Aviv, Tel Aviv
HeadquartersTel Aviv, Tel Aviv
Founded2011
Founded2011
Employees12
Employees12
CMMB Key Statistics
Market cap11.36M
Market cap11.36M
Price-Earnings ratio-1.08
Price-Earnings ratio-1.08
Dividend yield—
Dividend yield—
Average volume56.68K
Average volume56.68K
High today$1.72
High today$1.72
Low today$1.57
Low today$1.57
Open price$1.68
Open price$1.68
Volume63.81K
Volume63.81K
52 Week high$5.88
52 Week high$5.88
52 Week low$1.35
52 Week low$1.35
CMMB News
TipRanks 5d
Chemomab Therapeutics Sets April 28, 2026 Shareholder Meeting to Vote on Capital Increase and Governance MattersChemomab Therapeutics ( (CMMB) ) has issued an update. Chemomab Therapeutics has called its Annual General Meeting of shareholders for April 28, 2026, in Ramat...
TipRanks 7d
Chemomab Therapeutics reports FY25 EPS (1c) vs. (4c) last year“2025 was a critical year for Chemomab and our nebokitug program,” said Adi Mor, PhD, co-founder and Chief Executive Officer of Chemomab. “Our Phase 2 SPRING tr...
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.